[6-K] GSK plc American Current Report (Foreign Issuer)
GSK plc reports its issued share capital and total voting rights as of 31 August 2025. The company had 4,315,396,096 Ordinary Shares of 31 pence each, of which 244,408,471 were held in Treasury, leaving a total of 4,070,987,625 voting rights. Shareholders may use this figure as the denominator to determine whether they must notify changes in their holdings under the FCA Disclosure Guidance and Transparency Rules.
GSK plc comunica il proprio capitale sociale emesso e il totale dei diritti di voto al 31 agosto 2025. La società aveva 4.315.396.096 Azioni Ordinarie da 31 pence ciascuna, di cui 244.408.471 detenute in portafoglio (Treasury), lasciando un totale di 4.070.987.625 diritti di voto. Gli azionisti possono utilizzare questo numero come denominatore per stabilire se sono tenuti a notificare variazioni nelle loro partecipazioni ai sensi delle FCA Disclosure Guidance and Transparency Rules.
GSK plc informa sobre su capital social emitido y el total de derechos de voto a fecha 31 de agosto de 2025. La compañía tenía 4.315.396.096 Acciones Ordinarias de 31 peniques cada una, de las cuales 244.408.471 estaban en tesorería, quedando un total de 4.070.987.625 derechos de voto. Los accionistas pueden usar esta cifra como denominador para determinar si deben notificar cambios en sus participaciones conforme a las FCA Disclosure Guidance and Transparency Rules.
GSK plc는 2025년 8월 31일 기준 발행 주식 자본 및 총 의결권 수를 보고합니다. 회사는 액면가 31페니스의 보통주 4,315,396,096주를 보유하고 있었으며, 그중 244,408,471주는 자사주(Treasury)로 보유되어 총 4,070,987,625 의결권이 남습니다. 주주들은 이 수치를 분모로 사용하여 FCA Disclosure Guidance and Transparency Rules에 따른 보유 지분 변동 통지 의무 여부를 판단할 수 있습니다.
GSK plc annonce son capital social émis et le nombre total de droits de vote au 31 août 2025. La société détenait 4 315 396 096 actions ordinaires de 31 pence chacune, dont 244 408 471 en trésorerie, laissant un total de 4.070.987.625 droits de vote. Les actionnaires peuvent utiliser ce chiffre comme dénominateur pour déterminer s'ils doivent notifier des changements de leurs participations en vertu des FCA Disclosure Guidance and Transparency Rules.
GSK plc berichtet über das ausgegebene Aktienkapital und die Gesamtzahl der Stimmrechte zum 31. August 2025. Das Unternehmen hielt 4.315.396.096 Stammaktien zu je 31 Pence, davon 244.408.471 als eigene Aktien (Treasury), sodass insgesamt 4.070.987.625 Stimmrechte verbleiben. Aktionäre können diese Zahl als Nenner nutzen, um zu beurteilen, ob sie gemäß den FCA Disclosure Guidance and Transparency Rules Änderungen ihrer Beteiligungen melden müssen.
- Provides exact share and voting figures: 4,315,396,096 issued shares and 4,070,987,625 total voting rights.
- Compliance with disclosure rules: Meets FCA Disclosure Guidance and Transparency Rule 5.6.1R requirements and supplies a contact for notifications.
- None.
Insights
TL;DR: Routine regulatory disclosure of issued share capital and voting rights; useful for investor notification thresholds.
This Form 6-K provides the precise share count and Treasury share figure required under FCA rules, enabling shareholders to calculate disclosure thresholds accurately. The disclosure is administrative and does not convey operating or financial performance information. No other corporate actions, changes to share classes, or amendments to capital structure are reported in this filing.
TL;DR: Compliance-focused filing confirming total voting rights; no material change beyond routine reporting.
The filing fulfills Transparency Rule requirements by stating the total issued shares and Treasury holdings as of a specific date and provides a contact for notifications. This supports market transparency but contains no information that would typically be considered market-moving on its own.
GSK plc comunica il proprio capitale sociale emesso e il totale dei diritti di voto al 31 agosto 2025. La società aveva 4.315.396.096 Azioni Ordinarie da 31 pence ciascuna, di cui 244.408.471 detenute in portafoglio (Treasury), lasciando un totale di 4.070.987.625 diritti di voto. Gli azionisti possono utilizzare questo numero come denominatore per stabilire se sono tenuti a notificare variazioni nelle loro partecipazioni ai sensi delle FCA Disclosure Guidance and Transparency Rules.
GSK plc informa sobre su capital social emitido y el total de derechos de voto a fecha 31 de agosto de 2025. La compañía tenía 4.315.396.096 Acciones Ordinarias de 31 peniques cada una, de las cuales 244.408.471 estaban en tesorería, quedando un total de 4.070.987.625 derechos de voto. Los accionistas pueden usar esta cifra como denominador para determinar si deben notificar cambios en sus participaciones conforme a las FCA Disclosure Guidance and Transparency Rules.
GSK plc는 2025년 8월 31일 기준 발행 주식 자본 및 총 의결권 수를 보고합니다. 회사는 액면가 31페니스의 보통주 4,315,396,096주를 보유하고 있었으며, 그중 244,408,471주는 자사주(Treasury)로 보유되어 총 4,070,987,625 의결권이 남습니다. 주주들은 이 수치를 분모로 사용하여 FCA Disclosure Guidance and Transparency Rules에 따른 보유 지분 변동 통지 의무 여부를 판단할 수 있습니다.
GSK plc annonce son capital social émis et le nombre total de droits de vote au 31 août 2025. La société détenait 4 315 396 096 actions ordinaires de 31 pence chacune, dont 244 408 471 en trésorerie, laissant un total de 4.070.987.625 droits de vote. Les actionnaires peuvent utiliser ce chiffre comme dénominateur pour déterminer s'ils doivent notifier des changements de leurs participations en vertu des FCA Disclosure Guidance and Transparency Rules.
GSK plc berichtet über das ausgegebene Aktienkapital und die Gesamtzahl der Stimmrechte zum 31. August 2025. Das Unternehmen hielt 4.315.396.096 Stammaktien zu je 31 Pence, davon 244.408.471 als eigene Aktien (Treasury), sodass insgesamt 4.070.987.625 Stimmrechte verbleiben. Aktionäre können diese Zahl als Nenner nutzen, um zu beurteilen, ob sie gemäß den FCA Disclosure Guidance and Transparency Rules Änderungen ihrer Beteiligungen melden müssen.
FAQ
What are the total voting rights for GSK (GSK) as of 31 August 2025?
How many Ordinary Shares does GSK (GSK) have issued as of 31 August 2025?
How many of GSK's shares were held in Treasury on 31 August 2025?
Why is the total voting rights figure important for shareholders of GSK (GSK)?
Who can shareholders contact with notifications regarding GSK (GSK)?
